Dorsey & Whitney Trust CO LLC Acquires 99 Shares of Agilent Technologies, Inc. (NYSE:A)

Dorsey & Whitney Trust CO LLC increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 1.8% during the fourth quarter, Holdings Channel reports. The firm owned 5,707 shares of the medical research company’s stock after acquiring an additional 99 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Agilent Technologies were worth $767,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in A. Vestal Point Capital LP bought a new stake in shares of Agilent Technologies during the third quarter valued at approximately $14,848,000. Empowered Funds LLC raised its position in shares of Agilent Technologies by 29.8% during the third quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock valued at $4,592,000 after buying an additional 7,111 shares during the last quarter. S.E.E.D. Planning Group LLC raised its position in shares of Agilent Technologies by 12.7% during the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock valued at $5,721,000 after buying an additional 4,805 shares during the last quarter. Miracle Mile Advisors LLC purchased a new position in shares of Agilent Technologies in the fourth quarter valued at $362,000. Finally, Massachusetts Financial Services Co. MA grew its holdings in shares of Agilent Technologies by 3.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after purchasing an additional 525,214 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Agilent Technologies Stock Up 0.0 %

Shares of A opened at $126.59 on Monday. The firm has a fifty day moving average price of $139.67 and a 200-day moving average price of $138.68. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $36.09 billion, a P/E ratio of 29.10, a P/E/G ratio of 3.56 and a beta of 1.11. Agilent Technologies, Inc. has a 12-month low of $121.45 and a 12-month high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. Equities research analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.78%. Agilent Technologies’s payout ratio is currently 22.76%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Sanford C. Bernstein cut their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Citigroup raised their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Bank of America cut their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Finally, Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $135.00 to $145.00 in a report on Monday, February 10th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.